Cognitive impairment in rapid-onset dystonia-parkinsonism

ABSTRACT Rapid‐onset dystonia‐parkinsonism (RDP) is caused by mutations in the ATP1A3 gene. This observational study sought to determine if cognitive performance is decreased in patients with RDP compared with mutation‐negative controls. We studied 22 familial RDP patients, 3 non‐motor‐manifesting m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Movement disorders 2014-03, Vol.29 (3), p.344-350
Hauptverfasser: Cook, Jared F., Hill, Deborah F., Snively, Beverly M., Boggs, Niki, Suerken, Cynthia K., Haq, Ihtsham, Stacy, Mark, McCall, W. Vaughn, Ozelius, Laurie J., Sweadner, Kathleen J., Brashear, Allison
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 350
container_issue 3
container_start_page 344
container_title Movement disorders
container_volume 29
creator Cook, Jared F.
Hill, Deborah F.
Snively, Beverly M.
Boggs, Niki
Suerken, Cynthia K.
Haq, Ihtsham
Stacy, Mark
McCall, W. Vaughn
Ozelius, Laurie J.
Sweadner, Kathleen J.
Brashear, Allison
description ABSTRACT Rapid‐onset dystonia‐parkinsonism (RDP) is caused by mutations in the ATP1A3 gene. This observational study sought to determine if cognitive performance is decreased in patients with RDP compared with mutation‐negative controls. We studied 22 familial RDP patients, 3 non‐motor‐manifesting mutation‐positive family members, 29 mutation‐negative family member controls in 9 families, and 4 unrelated RDP patients, totaling 58 individuals. We administered a movement disorder assessment, including the Burke‐Fahn‐Marsden Dystonia Rating Scale (BFMDRS) and the Unified Parkinson's Disease Rating Scale (UPDRS) and a cognitive battery of memory and learning, psychomotor speed, attention, and executive function. The cognitive battery was designed to evaluate a wide range of functions; recognition memory instruments were selected to be relatively pure measures of delayed memory, devoid of significant motor or vocal production limitations. Comparisons of standardized cognitive scores were assessed both with and without controlling for psychomotor speed and similarly for severity of depressive symptoms. A majority of RDP patients had onset of motor symptoms by age 25 and had initial symptom presentation in the upper body (face, mouth, or arm). Among patients, the BFMDRS (mean ± SD, 52.1 ± 29.5) and UPDRS motor subscore (29.8 ± 12.7) confirmed dystonia‐parkinsonism. The affected RDP patients performed more poorly, on average, than mutation‐negative controls for all memory and learning, psychomotor speed, attention, and executive function scores (all P ≤ 0.01). These differences persisted after controlling for psychomotor speed and severity of depressive symptoms. Impaired cognitive function may be a manifestation of ATP1A3 mutation and RDP. © 2014 International Parkinson and Movement Disorder Society
doi_str_mv 10.1002/mds.25790
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3960305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1508681087</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4810-c1c350e0b40356696c4d711b5c4ec74705ad32d6aa6b54caa5d2579c5b67dc5e3</originalsourceid><addsrcrecordid>eNp1kc1OGzEUha2qqISfRV-gitQNLAbujcf2ZFOJhn8RWEDVpeWxDTWdsaf2BMjb4xCISqWubMvf_XSuDiGfEfYQYLTfmrQ3YmIMH8gAGcWiyq-PZABVxQqKFVsnGyndAyAy5J_I-qgsKUfEARlPwp13vXuwQ9d2ysXW-n7o_DCqzpki-GT7oZmnPninik7F386nfE_tFlm7VU2y26_nJvlxfHQzOS0urk7OJgcXhS4rhEKjpgws1CVQxvmY69IIxJrp0mpRCmDK0JHhSvGalVopZharaFZzYTSzdJN8W3q7Wd1ao3O-qBrZRdeqOJdBOfn-x7tf8i48SDrmQIFlwc6rIIY_M5t62bqkbdMob8MsSWRQ8Ry1Ehn9-g96H2bR5_UWlKioEHwh3F1SOoaUor1dhUGQi0JkLkS-FJLZL3-nX5FvDWRgfwk8usbO_2-S08PrN2WxnHCpt0-riVyN5IIKJn9enkg-vT7_DjfHckqfAd7fpGQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1507837765</pqid></control><display><type>article</type><title>Cognitive impairment in rapid-onset dystonia-parkinsonism</title><source>MEDLINE</source><source>Wiley Online Library</source><creator>Cook, Jared F. ; Hill, Deborah F. ; Snively, Beverly M. ; Boggs, Niki ; Suerken, Cynthia K. ; Haq, Ihtsham ; Stacy, Mark ; McCall, W. Vaughn ; Ozelius, Laurie J. ; Sweadner, Kathleen J. ; Brashear, Allison</creator><creatorcontrib>Cook, Jared F. ; Hill, Deborah F. ; Snively, Beverly M. ; Boggs, Niki ; Suerken, Cynthia K. ; Haq, Ihtsham ; Stacy, Mark ; McCall, W. Vaughn ; Ozelius, Laurie J. ; Sweadner, Kathleen J. ; Brashear, Allison</creatorcontrib><description>ABSTRACT Rapid‐onset dystonia‐parkinsonism (RDP) is caused by mutations in the ATP1A3 gene. This observational study sought to determine if cognitive performance is decreased in patients with RDP compared with mutation‐negative controls. We studied 22 familial RDP patients, 3 non‐motor‐manifesting mutation‐positive family members, 29 mutation‐negative family member controls in 9 families, and 4 unrelated RDP patients, totaling 58 individuals. We administered a movement disorder assessment, including the Burke‐Fahn‐Marsden Dystonia Rating Scale (BFMDRS) and the Unified Parkinson's Disease Rating Scale (UPDRS) and a cognitive battery of memory and learning, psychomotor speed, attention, and executive function. The cognitive battery was designed to evaluate a wide range of functions; recognition memory instruments were selected to be relatively pure measures of delayed memory, devoid of significant motor or vocal production limitations. Comparisons of standardized cognitive scores were assessed both with and without controlling for psychomotor speed and similarly for severity of depressive symptoms. A majority of RDP patients had onset of motor symptoms by age 25 and had initial symptom presentation in the upper body (face, mouth, or arm). Among patients, the BFMDRS (mean ± SD, 52.1 ± 29.5) and UPDRS motor subscore (29.8 ± 12.7) confirmed dystonia‐parkinsonism. The affected RDP patients performed more poorly, on average, than mutation‐negative controls for all memory and learning, psychomotor speed, attention, and executive function scores (all P ≤ 0.01). These differences persisted after controlling for psychomotor speed and severity of depressive symptoms. Impaired cognitive function may be a manifestation of ATP1A3 mutation and RDP. © 2014 International Parkinson and Movement Disorder Society</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.25790</identifier><identifier>PMID: 24436111</identifier><identifier>CODEN: MOVDEA</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adult ; Age of Onset ; Aged ; Cognition Disorders - complications ; Cognition Disorders - genetics ; dystonia ; Dystonia - genetics ; DYT-12 ; Female ; Genetic Predisposition to Disease ; Humans ; Male ; Memory ; Middle Aged ; Movement disorders ; Movement Disorders - genetics ; Mutation ; Mutation - genetics ; Parkinson's disease ; Parkinsonian Disorders - complications ; Parkinsonian Disorders - genetics ; rapid-onset dystonia-parkinsonism ; RDP ; Sodium-Potassium-Exchanging ATPase - genetics</subject><ispartof>Movement disorders, 2014-03, Vol.29 (3), p.344-350</ispartof><rights>2014 International Parkinson and Movement Disorder Society</rights><rights>2014 International Parkinson and Movement Disorder Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4810-c1c350e0b40356696c4d711b5c4ec74705ad32d6aa6b54caa5d2579c5b67dc5e3</citedby><cites>FETCH-LOGICAL-c4810-c1c350e0b40356696c4d711b5c4ec74705ad32d6aa6b54caa5d2579c5b67dc5e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmds.25790$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmds.25790$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24436111$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cook, Jared F.</creatorcontrib><creatorcontrib>Hill, Deborah F.</creatorcontrib><creatorcontrib>Snively, Beverly M.</creatorcontrib><creatorcontrib>Boggs, Niki</creatorcontrib><creatorcontrib>Suerken, Cynthia K.</creatorcontrib><creatorcontrib>Haq, Ihtsham</creatorcontrib><creatorcontrib>Stacy, Mark</creatorcontrib><creatorcontrib>McCall, W. Vaughn</creatorcontrib><creatorcontrib>Ozelius, Laurie J.</creatorcontrib><creatorcontrib>Sweadner, Kathleen J.</creatorcontrib><creatorcontrib>Brashear, Allison</creatorcontrib><title>Cognitive impairment in rapid-onset dystonia-parkinsonism</title><title>Movement disorders</title><addtitle>Mov Disord</addtitle><description>ABSTRACT Rapid‐onset dystonia‐parkinsonism (RDP) is caused by mutations in the ATP1A3 gene. This observational study sought to determine if cognitive performance is decreased in patients with RDP compared with mutation‐negative controls. We studied 22 familial RDP patients, 3 non‐motor‐manifesting mutation‐positive family members, 29 mutation‐negative family member controls in 9 families, and 4 unrelated RDP patients, totaling 58 individuals. We administered a movement disorder assessment, including the Burke‐Fahn‐Marsden Dystonia Rating Scale (BFMDRS) and the Unified Parkinson's Disease Rating Scale (UPDRS) and a cognitive battery of memory and learning, psychomotor speed, attention, and executive function. The cognitive battery was designed to evaluate a wide range of functions; recognition memory instruments were selected to be relatively pure measures of delayed memory, devoid of significant motor or vocal production limitations. Comparisons of standardized cognitive scores were assessed both with and without controlling for psychomotor speed and similarly for severity of depressive symptoms. A majority of RDP patients had onset of motor symptoms by age 25 and had initial symptom presentation in the upper body (face, mouth, or arm). Among patients, the BFMDRS (mean ± SD, 52.1 ± 29.5) and UPDRS motor subscore (29.8 ± 12.7) confirmed dystonia‐parkinsonism. The affected RDP patients performed more poorly, on average, than mutation‐negative controls for all memory and learning, psychomotor speed, attention, and executive function scores (all P ≤ 0.01). These differences persisted after controlling for psychomotor speed and severity of depressive symptoms. Impaired cognitive function may be a manifestation of ATP1A3 mutation and RDP. © 2014 International Parkinson and Movement Disorder Society</description><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Cognition Disorders - complications</subject><subject>Cognition Disorders - genetics</subject><subject>dystonia</subject><subject>Dystonia - genetics</subject><subject>DYT-12</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Male</subject><subject>Memory</subject><subject>Middle Aged</subject><subject>Movement disorders</subject><subject>Movement Disorders - genetics</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>Parkinson's disease</subject><subject>Parkinsonian Disorders - complications</subject><subject>Parkinsonian Disorders - genetics</subject><subject>rapid-onset dystonia-parkinsonism</subject><subject>RDP</subject><subject>Sodium-Potassium-Exchanging ATPase - genetics</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1OGzEUha2qqISfRV-gitQNLAbujcf2ZFOJhn8RWEDVpeWxDTWdsaf2BMjb4xCISqWubMvf_XSuDiGfEfYQYLTfmrQ3YmIMH8gAGcWiyq-PZABVxQqKFVsnGyndAyAy5J_I-qgsKUfEARlPwp13vXuwQ9d2ysXW-n7o_DCqzpki-GT7oZmnPninik7F386nfE_tFlm7VU2y26_nJvlxfHQzOS0urk7OJgcXhS4rhEKjpgws1CVQxvmY69IIxJrp0mpRCmDK0JHhSvGalVopZharaFZzYTSzdJN8W3q7Wd1ao3O-qBrZRdeqOJdBOfn-x7tf8i48SDrmQIFlwc6rIIY_M5t62bqkbdMob8MsSWRQ8Ry1Ehn9-g96H2bR5_UWlKioEHwh3F1SOoaUor1dhUGQi0JkLkS-FJLZL3-nX5FvDWRgfwk8usbO_2-S08PrN2WxnHCpt0-riVyN5IIKJn9enkg-vT7_DjfHckqfAd7fpGQ</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Cook, Jared F.</creator><creator>Hill, Deborah F.</creator><creator>Snively, Beverly M.</creator><creator>Boggs, Niki</creator><creator>Suerken, Cynthia K.</creator><creator>Haq, Ihtsham</creator><creator>Stacy, Mark</creator><creator>McCall, W. Vaughn</creator><creator>Ozelius, Laurie J.</creator><creator>Sweadner, Kathleen J.</creator><creator>Brashear, Allison</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201403</creationdate><title>Cognitive impairment in rapid-onset dystonia-parkinsonism</title><author>Cook, Jared F. ; Hill, Deborah F. ; Snively, Beverly M. ; Boggs, Niki ; Suerken, Cynthia K. ; Haq, Ihtsham ; Stacy, Mark ; McCall, W. Vaughn ; Ozelius, Laurie J. ; Sweadner, Kathleen J. ; Brashear, Allison</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4810-c1c350e0b40356696c4d711b5c4ec74705ad32d6aa6b54caa5d2579c5b67dc5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Cognition Disorders - complications</topic><topic>Cognition Disorders - genetics</topic><topic>dystonia</topic><topic>Dystonia - genetics</topic><topic>DYT-12</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Male</topic><topic>Memory</topic><topic>Middle Aged</topic><topic>Movement disorders</topic><topic>Movement Disorders - genetics</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>Parkinson's disease</topic><topic>Parkinsonian Disorders - complications</topic><topic>Parkinsonian Disorders - genetics</topic><topic>rapid-onset dystonia-parkinsonism</topic><topic>RDP</topic><topic>Sodium-Potassium-Exchanging ATPase - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cook, Jared F.</creatorcontrib><creatorcontrib>Hill, Deborah F.</creatorcontrib><creatorcontrib>Snively, Beverly M.</creatorcontrib><creatorcontrib>Boggs, Niki</creatorcontrib><creatorcontrib>Suerken, Cynthia K.</creatorcontrib><creatorcontrib>Haq, Ihtsham</creatorcontrib><creatorcontrib>Stacy, Mark</creatorcontrib><creatorcontrib>McCall, W. Vaughn</creatorcontrib><creatorcontrib>Ozelius, Laurie J.</creatorcontrib><creatorcontrib>Sweadner, Kathleen J.</creatorcontrib><creatorcontrib>Brashear, Allison</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cook, Jared F.</au><au>Hill, Deborah F.</au><au>Snively, Beverly M.</au><au>Boggs, Niki</au><au>Suerken, Cynthia K.</au><au>Haq, Ihtsham</au><au>Stacy, Mark</au><au>McCall, W. Vaughn</au><au>Ozelius, Laurie J.</au><au>Sweadner, Kathleen J.</au><au>Brashear, Allison</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive impairment in rapid-onset dystonia-parkinsonism</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov Disord</addtitle><date>2014-03</date><risdate>2014</risdate><volume>29</volume><issue>3</issue><spage>344</spage><epage>350</epage><pages>344-350</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><coden>MOVDEA</coden><abstract>ABSTRACT Rapid‐onset dystonia‐parkinsonism (RDP) is caused by mutations in the ATP1A3 gene. This observational study sought to determine if cognitive performance is decreased in patients with RDP compared with mutation‐negative controls. We studied 22 familial RDP patients, 3 non‐motor‐manifesting mutation‐positive family members, 29 mutation‐negative family member controls in 9 families, and 4 unrelated RDP patients, totaling 58 individuals. We administered a movement disorder assessment, including the Burke‐Fahn‐Marsden Dystonia Rating Scale (BFMDRS) and the Unified Parkinson's Disease Rating Scale (UPDRS) and a cognitive battery of memory and learning, psychomotor speed, attention, and executive function. The cognitive battery was designed to evaluate a wide range of functions; recognition memory instruments were selected to be relatively pure measures of delayed memory, devoid of significant motor or vocal production limitations. Comparisons of standardized cognitive scores were assessed both with and without controlling for psychomotor speed and similarly for severity of depressive symptoms. A majority of RDP patients had onset of motor symptoms by age 25 and had initial symptom presentation in the upper body (face, mouth, or arm). Among patients, the BFMDRS (mean ± SD, 52.1 ± 29.5) and UPDRS motor subscore (29.8 ± 12.7) confirmed dystonia‐parkinsonism. The affected RDP patients performed more poorly, on average, than mutation‐negative controls for all memory and learning, psychomotor speed, attention, and executive function scores (all P ≤ 0.01). These differences persisted after controlling for psychomotor speed and severity of depressive symptoms. Impaired cognitive function may be a manifestation of ATP1A3 mutation and RDP. © 2014 International Parkinson and Movement Disorder Society</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>24436111</pmid><doi>10.1002/mds.25790</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0885-3185
ispartof Movement disorders, 2014-03, Vol.29 (3), p.344-350
issn 0885-3185
1531-8257
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3960305
source MEDLINE; Wiley Online Library
subjects Adult
Age of Onset
Aged
Cognition Disorders - complications
Cognition Disorders - genetics
dystonia
Dystonia - genetics
DYT-12
Female
Genetic Predisposition to Disease
Humans
Male
Memory
Middle Aged
Movement disorders
Movement Disorders - genetics
Mutation
Mutation - genetics
Parkinson's disease
Parkinsonian Disorders - complications
Parkinsonian Disorders - genetics
rapid-onset dystonia-parkinsonism
RDP
Sodium-Potassium-Exchanging ATPase - genetics
title Cognitive impairment in rapid-onset dystonia-parkinsonism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A35%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20impairment%20in%20rapid-onset%20dystonia-parkinsonism&rft.jtitle=Movement%20disorders&rft.au=Cook,%20Jared%20F.&rft.date=2014-03&rft.volume=29&rft.issue=3&rft.spage=344&rft.epage=350&rft.pages=344-350&rft.issn=0885-3185&rft.eissn=1531-8257&rft.coden=MOVDEA&rft_id=info:doi/10.1002/mds.25790&rft_dat=%3Cproquest_pubme%3E1508681087%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1507837765&rft_id=info:pmid/24436111&rfr_iscdi=true